This speculation could be supported by the studies showing that TLR2 and its gene polymorphism were robustly associated with the increased levels of inflammatory mediators and development of PAH in patients with systemic sclerosis.37, 38. The gene discussed is TLR2; the disease is systemic sclerosis.